1-6 of 6
Li Weng, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison Of Deep Sequencing and Allele-Specific Oligonucleotide PCR Methods For MRD Quantitation In Acute Lymphoblastic Leukemia and Mantle Cell Lymphoma: CALGB 10403 and CALGB 59909 (Alliance)

Greg Malnassy, MS, Susan Geyer, PhD, Noreen Fulton, B.S., Greg Koval, B.S., Donna Niedzwiecki, PhD, Victoria Carlton, PhD, Li Weng, PhD, Lawrence D. Kaplan, MD, Guido Marcucci, MD, Lloyd E Damon, MD, Richard A. Larson, MD, Richard M. Stone, MD, Bruce D. Cheson, M.D., Malek Faham, MD, PhD, Wendy Stock, M.D.
Journal: Blood
Blood (2013) 122 (21): 2547.
https://doi.org/10.1182/blood.V122.21.2547.2547
Published: 2013
Journal Articles

Use Of Rearranged Immune Receptor Sequencing To Measure Minimal Residual Disease (MRD) In Bone Marrow, Cerebrospinal Fluid and Testes In Relapsed Childhood Acute Lymphoblastic Leukemia

Norman J. Lacayo, MD, Li Weng, PhD, Charles Gawad, MD, Malek Faham, MD, PhD, Gary V Dahl, MD
Journal: Blood
Blood (2013) 122 (21): 4984.
https://doi.org/10.1182/blood.V122.21.4984.4984
Published: 2013
Journal Articles

Minimal Residual Disease Measurement By Deep Sequencing Reflects Changes In Disease Load During Therapy In Diffuse Large B Cell Lymphoma Patients

Nina Wagner-Johnston, MD, Nancy L. Bartlett, MD, Kenneth R. Carson, MD, Mary Anderson, Li Weng, PhD, Mark Klinger, PhD, Malek Faham, MD, PhD, Richard F. Ambinder
Journal: Blood
Blood (2013) 122 (21): 1785.
https://doi.org/10.1182/blood.V122.21.1785.1785
Published: 2013
Journal Articles

Minimal Residual Disease (MRD) Detection By Deep Sequencing In Newly Diagnosed Multiple Myeloma Patients Treated With Carfilzomib, Lenalidomide and Dexamethasone

Sham Mailankody, MD, Neha Korde, MD, Malek Faham, MD, PhD, Mary Kwok, MD, Elisabet E. Manasanch, MD, Manisha Bhutani, MD, Nishant Tageja, MD, Dickran Kazandjian, Li Weng, PhD, Martin Moorhead, PhD, Rene Costello, Yong Zhang, PhD, Adriana Zingone, MD, PhD, Debbie Burton, Peter Wu, Marcia Mulquin, RN, Diamond Zuchlinski, RN, Roger Kurlander, MD, Irina Maric, MD, Katherine R Calvo, MD, PhD, Raul C. Braylan, Constance Yuan, MD, PhD, Maryalice Stetler-Stevenson, MD, PhD, Diane C Arthur, M.D., Mark Roschewski, MD, Ola Landgren, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1902.
https://doi.org/10.1182/blood.V122.21.1902.1902
Published: 2013
Journal Articles

Prognostic Value Of Deep Sequencing Approach For Minimal Residual Disease (MRD) Detection In Multiple Myeloma Patients

Joaquin Martinez-Lopez, MD, PhD, Juan José Laheurta, Francois Pepin, Marcos González, MD, Santiago Barrio, PhD, Rosa M. Ayala, MD, PhD, Noemí Puig, Maria Angeles Montalban, Bruno Paiva, Li Weng, PhD, Cristina Jimenez, Maria Sopena, Teresa Cedena, Inmaculada Rapado, Maria Victoria Mateo, Laura Rosiñol, MD, Albert Oriol, MD, María Jesús Blanchard, Rafael Martinez, MD, Joan Blade, MD, Jesus F San Miguel, Malek Faham, MD, PhD, Ramon Garcia-Sanz
Journal: Blood
Blood (2013) 122 (21): 1848.
https://doi.org/10.1182/blood.V122.21.1848.1848
Published: 2013
Journal Articles

Clonosight: A Standardized Clinical Assay for Measurement of Minimal Residual Disease in Leukemias and Lymphomas

Thomas D. Willis, PhD, Tom Asbury, PhD, Victoria Carlton, PhD, Lei Fang, PhD, Mark Klinger, PhD, Martin Moorhead, PhD, Kaliprasad Pothuraju, MS, Li Weng, PhD, Jianbiao Zheng, PhD, Malek Faham, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1434.
https://doi.org/10.1182/blood.V120.21.1434.1434
Published: 2012